Avalo Therapeutics
AVTX
AVTX
43 hedge funds and large institutions have $88.5M invested in Avalo Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
43
Holders Change
+6
Holders Change %
+16.22%
% of All Funds
0.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
14
Reduced
9
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$18.5M |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$1.06M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$243K |
| 4 |
Millennium Management
New York
|
+$168K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$136K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$60K |
| 2 |
WG
Winton Group
London,
United Kingdom
|
-$60K |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
-$56K |
| 4 |
BlackRock
New York
|
-$42.8K |
| 5 |
SIM
Spark Investment Management
New York
|
-$38.8K |
